A TRPM4-mediated decrease in Ca2+ entry has been observed in various cellular systems, including immune, cancer, cardiac muscle, and dental pulp cells [1,3,4,5,6,7,8,9,10,11]; however, other groups have found that TRPM4 mediates an increase in Ca2+ entry [12,13,14]. The gene discussed is TRPM4; the disease is cancer.